Back to top

SYRE Maintained by Guggenheim -- Price Target Raised to $130

SYRE Maintained by Guggenheim -- Price Target Raised to $130

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Spyre Therapeutics, Inc. (SYRE)